Denver Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$200K Hold
2,586
0.01% 402
2017
Q4
$218K Hold
2,586
0.01% 400
2017
Q3
$221K Sell
2,586
-40
-2% -$3.28K 0.01% 416
2017
Q2
$216K Hold
2,626
0.01% 424
2017
Q1
$221K Sell
2,626
-7,809
-75% -$625K 0.01% 429
2016
Q4
$767K Sell
10,435
-200
-2% -$14.9K 0.03% 274
2016
Q3
$854K Sell
10,635
-104
-1% -$8.32K 0.04% 277
2016
Q2
$846K Hold
10,739
0.04% 288
2016
Q1
$773K Buy
10,739
+294
+3% +$22.2K 0.03% 292
2015
Q4
$880K Sell
10,445
-1,304
-11% -$108K 0.04% 280
2015
Q3
$983K Sell
11,749
-931
-7% -$78.6K 0.04% 274
2015
Q2
$1.06M Hold
12,680
0.04% 284
2015
Q1
$921K Sell
12,680
-1,000
-7% -$71.2K 0.03% 360
2014
Q4
$944K Hold
13,680
0.03% 362
2014
Q3
$887K Buy
13,680
+1,000
+8% +$63.3K 0.03% 360
2014
Q2
$788K Sell
12,680
-300
-2% -$17.9K 0.02% 376
2014
Q1
$764K Sell
12,980
-400
-3% -$22.3K 0.02% 383
2013
Q4
$682 Buy
13,380
+85
+0.6% +$4.26K 0.02% 403
2013
Q3
$669K Hold
13,295
0.01% 429
2013
Q2
$653K Buy
+13,295
New +$723K 0.02% 423

Other funds holding LLY

Denver Investment Advisors's LLY Position: Q1 2018 in Review

Denver Investment Advisors held its Eli Lilly (LLY) position steady in Q1 2018 at 2,586 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #402.

Denver Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 20 quarters since. The position peaked at $1.06M in Q2 2015. 1,334 funds tracked by Wall St. Rank hold LLY as of Q1 2018.

  • Denver Investment Advisors held 2,586 shares of Eli Lilly worth $200K as of Q1 2018.
  • Denver Investment Advisors left its Eli Lilly share count unchanged in Q1 2018.
  • Eli Lilly made up 0.01% of Denver Investment Advisors's portfolio in Q1 2018, its #402 holding.
  • Denver Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 20 quarters since.
  • Denver Investment Advisors's Eli Lilly position peaked at $1.06M in Q2 2015.
  • 1,334 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.